Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number
Hematopoietic stem cell (HSC) gene therapy using integrating vectors has a potential leukemogenic risk due to insertional mutagenesis. To reduce this risk, a limitation of ≤2 average vector copy number (VCN) per cell is generally accepted. We developed an assay for VCN among transduced CD34+ cells t...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116301810 |
id |
doaj-9299f1f68c0e4f92aaa63be0d4ba2ab5 |
---|---|
record_format |
Article |
spelling |
doaj-9299f1f68c0e4f92aaa63be0d4ba2ab52020-11-24T20:56:13ZengElsevierMolecular Therapy: Nucleic Acids2162-25312013-01-012C10.1038/mtna.2013.49Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy NumberNaoya Uchida0Molly E Evans1Matthew M Hsieh2Aylin C Bonifacino3Allen E Krouse4Mark E Metzger5Stephanie E Sellers6Cynthia E Dunbar7Robert E Donahue8John F Tisdale9Molecular and Clinical Hematology Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, USAMolecular and Clinical Hematology Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, USAMolecular and Clinical Hematology Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, USAHematology Branch, NHLBI, NIH, Rockville, Maryland, USAHematology Branch, NHLBI, NIH, Rockville, Maryland, USAHematology Branch, NHLBI, NIH, Rockville, Maryland, USAHematology Branch, NHLBI, NIH, Bethesda, Maryland, USAHematology Branch, NHLBI, NIH, Bethesda, Maryland, USAHematology Branch, NHLBI, NIH, Rockville, Maryland, USAMolecular and Clinical Hematology Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, USAHematopoietic stem cell (HSC) gene therapy using integrating vectors has a potential leukemogenic risk due to insertional mutagenesis. To reduce this risk, a limitation of ≤2 average vector copy number (VCN) per cell is generally accepted. We developed an assay for VCN among transduced CD34+ cells that reliably predicts in vivo VCN in 16 rhesus recipients of CD34+ cells transduced with a green fluorescent protein (GFP) (or yellow fluorescent protein (YFP))-encoding lentiviral vector. Using GFP (or YFP)-specific probe/primers by real-time PCR, VCN among transduced CD34+ cells had no correlation with VCN among granulocytes or lymphocytes in vivo assayed 6 months post-transplantation. This was a likely result of residual plasmids present in the vector preparation. We then designed self-inactivating long terminal repeat (SIN-LTR)-specific probe/primers, which detect only integrated provirus. Evaluation with SIN-LTR probe/primers resulted in a positive correlation of VCN among transduced CD34+ cells with granulocytes and lymphocytes in vivo. The transduced CD34+ cells had higher VCN (25.1 ± 5.6) as compared with granulocytes (2.8 ± 1) and lymphocytes (2.4 ± 0.7). In summary, an integrated provirus-specific real-time PCR system demonstrated nine- to tenfold higher VCN in transduced CD34+ cells in vitro, as compared with VCN in vivo. Therefore, the restriction of ≤2 VCN before infusion might unnecessarily limit gene transfer efficacy.http://www.sciencedirect.com/science/article/pii/S2162253116301810CD34+ cellshematopoietic stem cell transplantationlarge animal modellentiviral vector |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Naoya Uchida Molly E Evans Matthew M Hsieh Aylin C Bonifacino Allen E Krouse Mark E Metzger Stephanie E Sellers Cynthia E Dunbar Robert E Donahue John F Tisdale |
spellingShingle |
Naoya Uchida Molly E Evans Matthew M Hsieh Aylin C Bonifacino Allen E Krouse Mark E Metzger Stephanie E Sellers Cynthia E Dunbar Robert E Donahue John F Tisdale Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number Molecular Therapy: Nucleic Acids CD34+ cells hematopoietic stem cell transplantation large animal model lentiviral vector |
author_facet |
Naoya Uchida Molly E Evans Matthew M Hsieh Aylin C Bonifacino Allen E Krouse Mark E Metzger Stephanie E Sellers Cynthia E Dunbar Robert E Donahue John F Tisdale |
author_sort |
Naoya Uchida |
title |
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number |
title_short |
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number |
title_full |
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number |
title_fullStr |
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number |
title_full_unstemmed |
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number |
title_sort |
integration-specific in vitro evaluation of lentivirally transduced rhesus cd34+ cells correlates with in vivo vector copy number |
publisher |
Elsevier |
series |
Molecular Therapy: Nucleic Acids |
issn |
2162-2531 |
publishDate |
2013-01-01 |
description |
Hematopoietic stem cell (HSC) gene therapy using integrating vectors has a potential leukemogenic risk due to insertional mutagenesis. To reduce this risk, a limitation of ≤2 average vector copy number (VCN) per cell is generally accepted. We developed an assay for VCN among transduced CD34+ cells that reliably predicts in vivo VCN in 16 rhesus recipients of CD34+ cells transduced with a green fluorescent protein (GFP) (or yellow fluorescent protein (YFP))-encoding lentiviral vector. Using GFP (or YFP)-specific probe/primers by real-time PCR, VCN among transduced CD34+ cells had no correlation with VCN among granulocytes or lymphocytes in vivo assayed 6 months post-transplantation. This was a likely result of residual plasmids present in the vector preparation. We then designed self-inactivating long terminal repeat (SIN-LTR)-specific probe/primers, which detect only integrated provirus. Evaluation with SIN-LTR probe/primers resulted in a positive correlation of VCN among transduced CD34+ cells with granulocytes and lymphocytes in vivo. The transduced CD34+ cells had higher VCN (25.1 ± 5.6) as compared with granulocytes (2.8 ± 1) and lymphocytes (2.4 ± 0.7). In summary, an integrated provirus-specific real-time PCR system demonstrated nine- to tenfold higher VCN in transduced CD34+ cells in vitro, as compared with VCN in vivo. Therefore, the restriction of ≤2 VCN before infusion might unnecessarily limit gene transfer efficacy. |
topic |
CD34+ cells hematopoietic stem cell transplantation large animal model lentiviral vector |
url |
http://www.sciencedirect.com/science/article/pii/S2162253116301810 |
work_keys_str_mv |
AT naoyauchida integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT mollyeevans integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT matthewmhsieh integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT aylincbonifacino integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT allenekrouse integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT markemetzger integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT stephanieesellers integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT cynthiaedunbar integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT robertedonahue integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber AT johnftisdale integrationspecificinvitroevaluationoflentivirallytransducedrhesuscd34cellscorrelateswithinvivovectorcopynumber |
_version_ |
1716790342326419456 |